These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
819 related articles for article (PubMed ID: 17270543)
1. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW; Appfelstaedt J; Zaahl MG J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543 [TBL] [Abstract][Full Text] [Related]
2. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
4. A review of genetic mutation in familial Hirschsprung's disease in South Africa: towards genetic counseling. Moore SW; Zaahl MG J Pediatr Surg; 2008 Feb; 43(2):325-9. PubMed ID: 18280283 [TBL] [Abstract][Full Text] [Related]
5. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene]. Fitze G; Saeger HD; Roesner D; Schackert HK Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293 [TBL] [Abstract][Full Text] [Related]
6. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480 [TBL] [Abstract][Full Text] [Related]
7. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma]. Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799 [TBL] [Abstract][Full Text] [Related]
8. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]. Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997 [TBL] [Abstract][Full Text] [Related]
9. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899 [TBL] [Abstract][Full Text] [Related]
10. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report. Menon MM; Simha MR Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654 [TBL] [Abstract][Full Text] [Related]
11. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Kaldrymides P; Mytakidis N; Anagnostopoulos T; Vassiliou M; Tertipi A; Zahariou M; Rampias T; Koutsodontis G; Konstantopoulou I; Ladopoulou A; Bei T; Yannoukakos D Clin Endocrinol (Oxf); 2006 May; 64(5):561-6. PubMed ID: 16649977 [TBL] [Abstract][Full Text] [Related]
12. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation. Moore SW; Zaahl M J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359 [TBL] [Abstract][Full Text] [Related]
13. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]. Pomares Gómez FJ; Bernabé Espinosa MJ; Matías-Guiu Guía X; Rodríguez González JM; Soriano Palao J; Sola Pérez J; Carbonell Meseguer P; Parrilla Paricio P; Tébar Massó FJ Med Clin (Barc); 1999 May; 112(17):646-50. PubMed ID: 10374185 [TBL] [Abstract][Full Text] [Related]
14. Management of patients with hereditary medullary thyroid carcinoma. Fitze G Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638 [TBL] [Abstract][Full Text] [Related]
15. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172 [TBL] [Abstract][Full Text] [Related]
17. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Krampitz GW; Norton JA Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901 [TBL] [Abstract][Full Text] [Related]
18. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes. Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208 [TBL] [Abstract][Full Text] [Related]